Correction: Corrigendum: CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients
Su, Shu,Hu, Bian,Shao, Jie,Shen, Bin,Du, Juan,Du, Yinan,Zhou, Jiankui,Yu, Lixia,Zhang, Lianru,Chen, Fangjun,Sha, Huizi,Cheng, Lei,Meng, Fanyan,Zou, Zhengyun,Huang, Xingxu,Liu, Baorui
DOI: https://doi.org/10.1038/srep40272
IF: 4.6
2017-01-01
Scientific Reports
Abstract:Scientific Reports 6: Article number: 20070; published online: 28 January 2016; updated: 19 January 2017. In figure 4d the micrograph for Patient 1 at 7 days was inadvertently duplicated for the Healthy Donor at day 7. The correct figure 4d appears below as Figure 1.